1). Katz J. Lumbar spine fusion: Surgical rate, costs and complications. Spine. 1995; 20:78–83.
2). Rothman RH, Booth R. Failures of spinal fusion. Orthop Clin North Am. 1975; 6:299–304.
Article
3). Steinmann JC, Herkowitz HN. Pseudoarthrosis of the spine. Clin Orthop. 1992; 284:80–90.
4). Dawson EG, Clader TJ, Bassett LW. A comparison of different methods used to diagnose pseudoarthrosis following posterior spinal fusion for scoliosis. J Bone Joint Surg Am. 1985; 67:1153–1159.
5). Brodsky AE, Kovalsky ES, Khalil MA. Correalation of radiologic assessment of lumbar spine fusion with surgical exploration. Spine. 1991; 16:261–265.
6). Zuckerman JF, Selby D, Delong WB. Failed posterior lumbar interbody fusion. White AH, Rothman RH, Ray CD, editors. Lumbar Spine Surgery. St Louis: CV Mosby;1987. p. 156–178.
7). Boden S. Overview of the biology of lumbar spine fusion and principle for selecting a bone graft substitute. Spine. 2002; 27:26–31.
8). Lane J, Sandhu H. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987; 18:213–225.
Article
9). Boden S, Summer D. Biologic factors affecting spinal fusion and bone regeneration. Spine. 1995; 20:102–112.
Article
10). Sandhu H, Boden S. Biologic enhancement of spinal fusion. Orthop Clin North Am. 1998; 29:621–631.
Article
11). Klawitter JJ, Bagwell JG, Weinstein AM, Sauer BW, Pruitt JR. An evaluation of bone growth into porous high density polyethylene. J Biomed Mater Res. 1976; 10:311–323.
Article
12). Holmes RE, Mooney V, Bucholz R, Tencer A. A coralline hydroxyapatite bone graft substitute. Clin Orthop Rel Res. 1984; 188:252–262.
Article
13). Banwart JC, Asher MA, Hanssanein RS. Iliac crest bone graft harvest donor site morbidity. Spine. 1995; 15:1055–1060.
Article
14). Wang JM, Kim DJ. Clinical Course of Iliac Bone Graft Donor Site Morbidity. Journal of Korean Spine Surg. 1996; 3:154–160.
15). Center for Disease Control. Transmission of HIV through bone transplantation: case report and publc health recommendation. JAMA. 1988; 260:2487–2488.
16). Buck B, Malinin T, Beown M. Bone transplantation and human immunodeficiency virus. Clin Orthop. 1989; 240:129–136.
Article
17). Pelker R, Friedlaender G. Biomechanical aspects of bone autografts and allografts. Orthop Clin North Am. 1987; 18:235–239.
Article
18). Hamer AJ, Strachan JR, Black MM, Ibbotson CJ, Stockley I, Elson RA. Biomechanical properties of cortical allograft bone using a new method of bone strength measurement: a comparison of fresh, fresh-frozen, and irradiated bone. J Bone Joint Surg Br. 1996; 78:363–368.
19). Prolo D, Pedrotti P, White D. Ethyelene oxide sterilization of bone, duramater and fascia lata for human transplantation. Neurosurgery. 1980; 6:529–539.
20). Herron L, Newman M. The failure of ethylene oxide gas sterilized freeze-dried bone graft for thoracic and lumbar spine fusion. Spine. 1989; 14:496–500.
21). An HS, Simpson JM, Glover JM, Stephany J. Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study. Spine. 1995; 20:2211–2216.
22). Brown M, Malinin T, Davis P. A roentgenographic evaluation of frozen allografts versus autografts in anterior interbody fusion. Clin Orthop. 1976; 119:231–236.
23). Cloward R. Gas-sterilized cadaver bone grafts for spinal fusion. Spine. 1980; 5:4–10.
24). Zhang Z, Yin H, Yang K. Anterior intervertebral disc excision and bone grafting in cervical spondylotic myelopathy. Spine. 1983; 8:16–22.
Article
25). Hanley E, Harvell J, Shapiro D, Kraus D. Use of allograft bone in cervical spine surgery. Sem Spine Surg. 1989; 1:262–270.
26). Zdeblick T, Ducker T. The use of freeze-dried allograft bone for anterior cervical fusion. Spine. 1991; 16:726–732.
27). Blumenthal S, Baker J, Dossett A, Selby D. The role of anterior lumbar fusion for internal disc disruption. Spine. 1988; 13:566–569.
Article
28). Kumar A, Kozak J, Doherty B. Interspace distraction and graft subsidence after anterior lumbar fusion after femoral strut allograft. Spine. 1993; 18:2392–2400.
29). Kozak J, Heilman A, O'Brien J. Anterior lumbar fusion options: technique and graft materials. Clin Orhop. 1994; 300:45–53.
Article
30). Butterman GR, Glazer PA, Bradford DS. The use of bone allografts in the spine. Clin Orthop. 1996; 324:75–85.
31). Auri B, Weierman R, Lowell H, Nadel C, Parson J. Pseudoarthrosis after spinal fusion for scoliosis: a comparison of autogenic and allogenic bone graft. Clin Orthop. 1985; 199:153–158.
32). McCarthy R, Peek R, Morrissy R, Hough A. Allograft bone in spinal fusion for paralytic scoliosis. Bone Joint Surg Am. 1986; 68:370–375.
Article
33). Jorgenson S, Lowe T, France J, Sabin J. A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. Spine. 1994; 19:2048–2053.
Article
34). An HS, Lynch K, Toth J. Prospective comparison of autograft vs allograft for adult posterolateral lumbar spine fusion; differences among freeze-dried, frozen, and mixed grafts. J Spinal Disord. 1995; 8:131–135.
35). Boden S, Schimandle J. Biologic enhancement of spinal fusion. Spine. 1995; 20:113–123.
Article
36). Jachro M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop. 1981; 157:259–278.
37). Flattley T, Lynch K, Benson M. Tissue response to implants of calcium phosphate ceramic in the rabbit spine. Clin Orthop. 1983; 179:246–252.
38). Ferrao J. Experimental evaluation of ceramic calcium phosphate as a substitute for bone grafts. Plast Reconstr Surg. 1979; 63:634–640.
39). Moore D, Chapman M, Manske D. The evaluation of a biphasic calcium phosphate ceramic for use in grafting long-bone diaphyseal defect. J Orthop Res. 1987; 5:356–365.
40). Daculsi G, LeGeros R, Nery E, Lynch K, Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo: ultrstructural and physicochemical characterization. J Biomed Mater Res. 1989; 23:883–894.
41). Guigui P, Plais P, Flature B. Experimental model of posterolateral spinal arthrodesis in sheep 1. Experimental procedures and results with autologous bone graft. Spine. 1994; 19:2791–2797.
42). Guigui P, Plais P, Flature B. Experimental model of posterolateral spinal arthrodesis in sheep 2. Application of the model: evaluation of vertebral fusion obtained with coral(Porties) or with a biphasic ceramic(Triosite). Spine. 1994; 19:2798–2803.
43). Emery S, Fuller D, Stevenson S. Ceramic anterior spinal fusion: biological and biomechanical comparison in a canine model. Spine. 1996; 21:2713–2719.
44). Boden S, Martin G, Morone M, Ugbo J, Moskovitz P. Posterolateral lumbar intertrnasverse process spine arthrodesis with recombinant human bone morphogenetic protein-2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine. 1999; 24:1179–1185.
45). Roudier M, Bouchon C, Rouvillain JL, et al. The resorption of bone-implanted corals varies with porosity but also with the host reaction. J Biomed Mater Res. 1995; 29:905–915.
Article
46). Holmes R, Bucholz R, Mooney V. Porous hydroxyapatite as a bone graft substitute in metaphyseal defects. J Bone Joint Surg Am. 1986; 68:904–911.
47). Guillemin P, Meunier A, Dallant P. Comparison of coral resoption and bone apposition with two natural corals of different porosity. J Biomed Mater Res. 1989; 23:765–779.
48). Damien C, Christel P, Benedict J, Patat J, Guillemin G. A composite of natural coral, collagen, bone protein, and basic fibroblast growth factor tested in a rat subcutaneous model. Ann Chir Gynecol. 1993; 82:117–128.
49). Steffen T, Marcheisi D, Aebi M. Posterolateral and anterior interbody fusion models in the sheep. Clin Orthop. 2000; 371:28–37.
50). Baramki H, Steffen T, Lander P, Chang M, Marcheisi D. The efficacy of interconnected porous hydroxyapatite in achieving posterior lumbar fusion in sheep. Spine. 2000; 25:1053–1060.
51). Fuller D, Stevenson S, Emery S. The effects of internal fixation on calcium carbonate: ceramic anterior spinal fusion in dogs. Spine. 1996; 21:2791–2797.
52). Passati N, Daculsi G, Rogez J, Martin S, Bainvel J. Macroporous calcium phosphate ceramic performance in human spine fusion. Clin Orthop. 1989; 248:169–176.
53). Heise U, Osborn J, Duwe F. Hydroxyapatite ceramic as a bone substitute. Int Orthop. 1990; 14:329–338.
Article
54). Marchesi D. Spinal fusion: bone and bone substitutes. Eur Spine J. 2000; 9:372–378.
55). Thalgott J, Fritts K, Ginffre J, Timlin M. Anterior interbody fusion of the cervical spine with coralline hydroxyapatite. Spine. 1999; 24:1295–1299.
Article
56). Urist M. Bone: formation by autoinduction. Science. 1965; 150:893–899.
Article
57). Sandhu HS, Grewal HS, Parvataneru H. Bone grafting for spinal fusion. Orthop Clin North Am. 1999; 30:685–698.
Article
58). Wang J, Glimcher MJ. Characterization of marix-induced osteogensis in a rat calvarial bone defect: I. Differences in the cellular response to demineralized bone matrix implanted in calvarial defects and subcutaneous sites. Calcif Tisseu Int. 1995; 65:156–165.
59). Morone MN, Boden SD. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix. Spine. 1998; 23:159–167.
60). Frenkel SR, Moskovich R, Spivak J, Zhang ZH, Prewett AB. Demineralized bone matrix. Enhancement of spinal fusion. Spine. 1993; 18:1634–1639.
61). Martin GJ, Boden SD, Titus L, Scaborough NL. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. Spine. 1999; 24:637–645.
Article
62). Helm GA, Sheeham JM, Sheeham JP, et al. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bonen lumbar spinal fusion. J Neurosurg. 1997; 86:93–100.
63). Schwartz Z, Somer A, Mellonig , et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation in dependent on donor age not gender. J Periodontol. 1998; 69:470–478.
64). Syftestad GT, Urist MR. Bone aging. Clin Orthop. 1982; 162:288–297.
Article
65). Jergenson HE, Chua J, Kao RT, Kaban LB. Age effects on bone induction by demineralized bone powder. Clin Orthop. 1991; 268:253–259.
66). Buring K, Urist MR. Effects of ionizing radiation on the bone induction principle in the matrix of bone implants. Clin Orthop. 1967; 357:219–228.
Article
67). Aspenberg P, Johnson E, Thorngren KG. Dose-dependent reduction of bone inductive properties by ethylene oxide. J Bone Joint Surg Br. 1990; 72:1036–1037.
Article
68). Zhang M, Powers RM, Wolfinbarger L. Effects of the demineralized process on the osteoinductivity of demineralized bone matrix. J Periodontol. 1997; 78:1085–1092.
69). Sassard WR, Eidman DK, Gray PM, et al. Augmenting local bone with Grafton demineralized bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopedics. 2000; 23:1059–1064.
Article
70). Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An unexpected outcome during testing of commercially available demineralized bone graft materials: how safe are the nonallograft components? Spine. 2001; 26:1425–1428.
71). Urist M, Strates B. Bone formation in implants of partially and wholly demineralized bone matrix. Clin Orthop. 1970; 71:271–278.
72). Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science. 1988; 242:1528–1534.
Article
73). Ozkaynak E, Schnegelsberg PNJ, Jin DF, et al. Osteogenic protein-2: A new member of the transforming growth factor- superfamily expressed early in embryogenesis. J Biol Chem. 1992; 267:25220–25227.
74). Wozney JM. Overview of bone morphogenetic proteins. Spine. 2002; 27:2–8.
Article
75). Gitelman SF, Kobrin MS, Ye J-Q, et al. Recombinant Vgr-1/BMP-6-expressing tumor induce fibrosis and enchondral bone formation in vivo. J Cell Biol. 1994; 126:1595–1609.
76). Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Bio Chem. 1992; 267:20352–20362.
Article
77). Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet. 2001; 27:84–88.
Article
78). Johnson E, Urist M, Finerman G. Repair of segmental defects of the tibia with human bone morphogenetic protein. Clin Orthop. 1988; 236:249–256.
79). Johnson E, Urist M, Finerman G. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: a preliminary report. Clin Orthop. 1988; 230:257–262.
80). Sandhu H. Kanim L, Kabo J, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine. 1996; 21:2115–2120.
Article
81). Urist M, Silverman B, Buring K, Dubuc F, Rosenberg J. The bone induction principle. Clin Orthop. 1967; 53:243–283.
82). Wozney J. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992; 32:160–167.
Article
83). Lovel T, Dawson E, Nilsson O, et al. Augmentation of spinal fusion with bone morphogenetic protein in dogs. Clin Orthop. 1987; 234:266–274.
84). Schimandle J, Boden S. Hutton W. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine. 1995; 20:1326–1337.
Article
85). Cook SD, Dalton JF, Tan EH, Whitecloud TS III, Rueger DC. In vivo evaluation of recombinant human osteognic protein(rhOP-1) implants as a bone graft substitute for spinal fusion. Spine. 1994; 19:1655–1663.
86). Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002; 15:337–349.
Article
87). Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine. 2002; 27:2662–2673.
88). Vaccaro AR, Patel T, Fischergrund J, et al. A pilot study evaluating the safety and efficacy of OP-1 putty(rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine. 2004; 29:1885–1892.
89). Vaccaro AR, Patel T, Fischergrund J, et al. A 2-year follow-up pilot study evaluating the safety and efficacy of OP-1 putty(rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J. 2005; 14:623–629.
90). Johnsson R, Stromqvist B, Aspenberg P. Randomized radiostereometric study comparing osteogenic protein-1 (OP-1) and autograft in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine. 2002; 27:2654–2661.
91). Shah RV, Albert TJ, Bruegel-Sanches V, Vaccaro AR, Hilibrand AS, Grauer JN. Industry support and correlation to study outcome for papers published in Spine. Spine. 2005; 30:1099–1104.
Article